D1-plus | D2 | P value | DF | Power 1-Betaa | |||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Sex | |||||||
Female | 40.0 | 43.0 | 39.0 | 43.0 | |||
Male | 53.0 | 57.0 | 54.0 | 57.0 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 1 | 1 | 0.98 |
Age (years) | |||||||
Mean; SD | 67.8 | 11.6 | 65.5 | 13.0 | |||
Median | 69.0 | 68.0 | |||||
Range | 31.0 | 87.0 | 29.0 | 88.0 | 0.20 | 0.98 | |
Procedure | |||||||
Sub-total Gastrectomies | 61.0 | 65.6 | 67.0 | 65.6 | |||
Total Gastrectomies | 32.0 | 34.4 | 26.0 | 34.4 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.42 | 1 | 0.98 |
T Stage | n | % | n | % | |||
T1 -T2 | 56.0 | 60.2 | 49.0 | 60.2 | |||
T3-T4 | 37.0 | 39.8 | 44.0 | 39.8 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.37 | 1 | 0.98 |
N Stage | |||||||
N0 | 34.0 | 36.6 | 32.0 | 36.6 | |||
N positive | 59.0 | 63.4 | 61.0 | 63.4 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.87 | 1 | 0.98 |
LNH | |||||||
Mean; SD | 27.2 | 12.5 | 31.2 | 13.9 | |||
Median | 26.0 | 29.0 | |||||
Range | 2.0 | 71.0 | 1.0 | 64.0 | 0.04 | 0.98 | |
N Positivity | |||||||
Mean; SD | 5.7 | 9.3 | 4.9 | 7.8 | |||
Median | 2.0 | 1.0 | |||||
Range | 0.0 | 48.0 | 0.0 | 40.0 | 0.53 | 0.98 | |
LNH < 15 | |||||||
LNH < 15 | 13.0 | 14.0 | 7.0 | 7.5 | |||
LNH ≥ 15 | 80.0 | 86.0 | 86.0 | 92.5 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.22 | 1 | 0.98 |
LNR | |||||||
LNR0 | 34.0 | 36.6 | 32.0 | 36.6 | |||
LNR1 | 9.0 | 9.7 | 15.0 | 9.7 | |||
LNR2 | 8.0 | 8.6 | 10.0 | 8.6 | |||
LNR3 | 13.0 | 14.0 | 10.0 | 14.0 | |||
LNR4 | 8.0 | 8.6 | 6.0 | 8.6 | |||
LNR5 | 21.0 | 22.6 | 20.0 | 22.6 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.77 | 5 | 0.9 |
Stage | |||||||
Stage 1–2 | 61.0 | 65.6 | 52.0 | 65.6 | |||
Stage 3–4 | 32.0 | 34.4 | 41.0 | 34.4 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.22 | 1 | 0.98 |
Grading | |||||||
G1-G2 | 26.0 | 28.6 | 32.0 | 38.1 | |||
G3-G4 | 65.0 | 71.4 | 52.0 | 61.9 | |||
Total | 91.0 | 100.0 | 84.0 | 100.0 | 0.23 | 1 | 0.97 |
Lauren Classification | |||||||
Intestinal | 49.0 | 73.1 | 51.0 | 66.2 | |||
Diffuse | 18.0 | 26.9 | 26.0 | 33.8 | |||
Total | 67.0 | 100.0 | 77.0 | 100.0 | 0.47 | 1 | 0.94 |
Adjuvant Chemotherapy | |||||||
Performed | 47.0 | 50.5 | 53.0 | 50.5 | |||
Not Performed | 46.0 | 49.5 | 40.0 | 49.5 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 0.46 | 1 | 0.98 |
Relapses | |||||||
Yes | 34.0 | 36.6 | 33.0 | 36.6 | |||
No | 59.0 | 63.4 | 60.0 | 63.4 | |||
Total | 93.0 | 100.0 | 93.0 | 100.0 | 1 | 1 | |
Follow up (months) | |||||||
Mean; SD | 36.8 | 26.4 | 83.5 | 68.9 | |||
Median | 32.5 | 63.0 | < 0.0001 | 0.98 | |||
Range | 3.0 | 100.0 | 3.0 | 267.0 |